Product NDC: | 0085-0924 |
Proprietary Name: | Lotrisone |
Non Proprietary Name: | Clotrimazole and Betamethasone dipropionate |
Active Ingredient(s): | .5; 10 mg/g; mg/g & nbsp; Clotrimazole and Betamethasone dipropionate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0085-0924 |
Labeler Name: | Merck Sharp & Dohme Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018827 |
Marketing Category: | NDA |
Start Marketing Date: | 19840710 |
Package NDC: | 0085-0924-02 |
Package Description: | 1 TUBE in 1 BOX (0085-0924-02) > 45 g in 1 TUBE |
NDC Code | 0085-0924-02 |
Proprietary Name | Lotrisone |
Package Description | 1 TUBE in 1 BOX (0085-0924-02) > 45 g in 1 TUBE |
Product NDC | 0085-0924 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clotrimazole and Betamethasone dipropionate |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 19840710 |
Marketing Category Name | NDA |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE |
Strength Number | .5; 10 |
Strength Unit | mg/g; mg/g |
Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |